Kathryn Fantauzzi

Kathryn Fantauzzi is the Co-Founder and CEO of Apollo Neuroscience, a company that has developed innovative wearable technology to improve energy, focus, and sleep.1 She played a crucial role in bringing this scientifically-validated device from the research lab to the market.

Background and Education

Kathryn holds a B.A. from Smith College and a Master of Public Administration (MPA) from the Rockefeller College of Public Affairs and Policy, with a focus on behavioral economics and finance.1 Her educational background has equipped her with the skills needed for her leadership role at Apollo Neuroscience.

Professional Experience

Prior to founding Apollo Neuroscience, Kathryn gained valuable experience in early-stage tech commercialization:

1. She worked on developing a $20 million tech commercialization accelerator through the NY State Energy Research & Development Authority.1
2. Kathryn led the Green Jobs Green NY initiative, overseeing a $13 million funding pool for sustainability projects.1

Apollo Neuroscience

In 2016, Kathryn joined the University of Pittsburgh research team to raise funding for clinical research on the Apollo device.1 After successful clinical trials, she co-founded Apollo Neuroscience with Dr. Dave Rabin and launched the product in January 2020.

As CEO, Kathryn has:

• Assembled a team of physicians, researchers, engineers, and designers to refine the Apollo technology.1
• Spearheaded the company's market strategy and product launch.
• Secured $4.5 million in funding to bring the product to market.

Personal

Kathryn is known for balancing her professional commitments with personal interests, including outdoor activities. She is passionate about bridging the gap between cutting-edge science and everyday well-being, making innovative health solutions accessible to the public.1